KALKOFEN DONALD A. (Chief Financial Officer) purchased 1.18K shares of PROTAGONIST THERAPEUTICS, INC on the open market
Open‑market purchase worth $6.0K. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 12/3/2019ACC: 0001209191-19-058800
Officer· Chief Financial Officer
Since May 2019
+1.18K
Net shares
Net buyer
$6.0K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
1.18K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+613.00
Price / share
$5.10
Trade value
$3.13K
% of position
New position
12/3/2019
0.00→613.00
Common Stock
Direct
Shares
+562.00
Price / share
$5.09
Trade value
$2.86K
% of position
91.7%
12/3/2019
613.00→1.18K
Total
Net shares
+1.18K
Net value
$5.99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/3/2019 | P · Purchase | +613.00 | $5.10 | $3.13K | New position | 0.00 | 613.00 |
| Common Stock Direct | 12/3/2019 | P · Purchase | +562.00 | $5.09 | $2.86K | 91.7% | 613.00 | 1.18K |
| Total | +1.18K | $5.99K | ||||||
Derivative Transactions0
No derivative transactions reported